Castomize Technologies Pte. Ltd.
Castomize is a pioneering advanced manufacturing startup using 4D-printing to positively impact multiple industries around the world.
Our first focus industry is medical devices, where we are are making healthcare more accessible, effective, and less invasive. Our first device, 4D-printed casts, are created using advanced fabrication techniques and customized blends of polymers to provide unprecedented comfort, convenience, and efficiency for patients, doctors, hospitals, and medical insurers.
Over 180 million patients experience fractures annually, a market worth around 6 billion USD. Castomize’s 4D-printed casts are the best contender to displace the century-old solutions of plaster and fibreglass casts, having been validated by six hospitals around APAC, and having a co-development agreement the National Healthcare Group to finalize our cast and create a device poised to take over as the new standard of fracture treatment.
Core to Castomize’s operations is the focus on sustainability and promotion of access to healthcare for everyone, everywhere. Castomize’s business model consists of re-manufacturing, where casts sold to hospitals are salvaged and converted into first-aid kits meant for fracture healing in earthquake disaster zones, as 56% of all injuries during earthquakes are fractures, and Japan would be a key customer due to the frequency of earthquakes.
Nominated by
A spin-off from Singapore University of Technology and Design, Castomize Technologies uses advanced manufacturing techniques to create new medical devices.
Castomize Technologies’s 4D-printed orthopaedic casts are more comfortable for patients through being lighter, fully waterproof and well-ventilated. For medical practitioner (e.g., doctors), the cast are provided easy and more accurate applicable, require less tools and time to apply. In addition, the cast are more sustainable for the environment as it uses fewer disposable tools and can be remoulded throughout the patient’s healing journey.
Castomize Technologies conducted trial with 5 hospitals in Singapore and has received positive feedbacks. It also has product co-development agreement with Singapore’s National Healthcare Group.
In the long-term, Castomize Technologies will be leveraging on its domain knowledge in 4D-printing to positively impact under industries such as packaging, advanced manufacturing, and other medical devices.
Castomize Technologies's solutions are very well suited to solving Japan's social challenges, and there is a high potential for partnerships with Japanese companies in a wide range of fields.